[1]
T. W. Herwati, Y. Yulistiani, and E. Z. M, “Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia”, FMI, vol. 54, no. 1, pp. 46–52, Apr. 2018.